Policy Roundup: Vaccine Safety Research, Measles Response, and AI in Healthcare
The NIH is advancing a new research center and a large study on vaccine harms, while House Democrats are requesting an immediate CDC briefing on the measles outbreak. HHS continues to pursue medical AI initiatives, including Medicare reimbursement pathways and FDA approvals for AI-enabled devices, despite noted risks. Other developments include the AMA backing a permanent Medicare physician payment fix and concerns over the NSF's shifting research priorities.
The NIH’s planned vaccine-safety research center and large-scale harms study are still in early formation, according to Science. Meanwhile, the CDC’s recent merger of its influenza and respiratory disease divisions was a change already in motion under the previous administration, as reported by CIDRAP. Separately, the AMA has thrown its weight behind a legislative proposal aimed at permanently overhauling Medicare physician payment, including inflation-linked updates and revised budget neutrality rules.
HHS continues to advance AI-enabled medical devices and Medicare reimbursement pathways, despite concerns raised in the New York Times. Anthropic has flagged five instances where its Claude AI was used in attempts to develop toxins or bioweapons, though intent remains unclear. The NSF’s shift away from individual grants toward technology projects has unsettled researchers, while Medicaid fraud enforcement is reportedly disrupting autism services for children.
This roundup highlights a convergence of policy shifts that could reshape healthcare delivery and trust. Vaccine-safety research and measles response may influence public confidence in immunization programs, while AI reimbursement and FDA approvals could alter clinical practice and patient access. Medicare payment reform and Medicaid enforcement may affect physician viability and vulnerable populations. The NSF’s priorities and anti-diversity efforts could impact the future research workforce and innovation. These changes may have uneven societal effects, depending on implementation and oversight.